Contribution of b cells and antibody to cardiac allograft vasculopathy

Transplantation

Volumn 88, Issue 4, 2009, Pages 470-477

  Gareau, Alison ^a   Hirsch, Gregory M ^a   Lee, Tim D G ^a   Nashan, Bjorn ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Allograft vasculopathy; Graft arteriosclerosis; Late graft rejection

Indexed keywords

ALLOANTIBODY; ALPHA ACTIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; GRAFT FAILURE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; MYOFIBROBLAST; NONHUMAN; ORGAN TRANSPLANTATION; PASSIVE TRANSPORT; PATHOGENESIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

ACTINS; ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; AORTA, ABDOMINAL; B-LYMPHOCYTES; CYCLOSPORINE; DISEASE MODELS, ANIMAL; HEART TRANSPLANTATION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 70349145843     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b076cc     Document Type: Article

References (43)

1. Registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2008; 27:937.
2. Hertz MI, Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: Nineteenth Official Report-2002. J Heart Lung Transplant 2002; 21: 950.
3. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Report-2001. J Heart Lung Transplant 2001; 20: 805.
4. Ramzy D, Rao V, Brahm J, et al. Cardiac allograft vasculopathy: A review. Can J Surg 2005; 48: 319.
5. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007; 100: 967.
6. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847.
7. Schwarze ML, Houser SL, Muniappan A, et al. Effects of mycopheno-late mofetil on cardiac allograft survival and cardiac allograft vascu-lopathy in miniature swine. Ann Thorac Surg 2005; 80: 1787.
8. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001; 7: 738.
9. Johnson P, Carpenter M, Hirsch G, et al. Recipient cells form the inti-mal proliferative lesion in the rat aortic model of allograft arteriosclerosis. Am J Transplant 2002; 2: 207.
10. Hillebrands JL, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 380.
11. Li J, Han X, Jiang J, et al. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol 2001; 158: 1943.
12. Saiura A, Sata M, Hirata Y, et al. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001; 7: 382.
13. Skaro AI, Liwski RS, O'Neill J, et al. Impairment of recipient cyto-lytic activity attenuates allograft vasculopathy. Transpl Immunol 2005; 14: 27.
14. Skaro AI, Liwski RS, Zhou J, et al. CD8 T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway. Cardiovasc Res 2005; 65: 283.
15. Vessie EL, Hirsch GM, Lee TD. Aortic allograft vasculopathy is mediated by CD8() T cells in cyclosporin A immunosuppressed mice. Transpl Immunol 2005; 15: 35.
16. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387.
17. Choy JC, Cruz RP, Kerjner A, et al. Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease. Am J Transplant 2005; 5: 494.
18. Rahmani M, Cruz RP, Granville DJ, et al. Allograft vasculopathy versus atherosclerosis. Circ Res 2006; 99: 801.
19. Krupnick AS, Kreisel D, Popma SH, et al. Mechanism of T cell-mediated endothelial apoptosis. Transplantation 2002; 74: 871.
20. Booth RF, Martin JF, Honey AC, et al. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989;76:257.
21. Reidy MA. Factors controlling smooth-muscle cell proliferation. Arch Pathol Lab Med 1992; 116: 1276.
22. Currie M, Zaki AM, Nejat S, et al. Immunologic targets in the etiology of allograft vasculopathy: Endothelium versus media. Transpl Immunol 2008; 19: 120.
23. Chow LH, Huh S, Jiang J, et al. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation 1996; 94: 3079.
24. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Im-munol 1994; 152: 5135.
25. Russell PS, Chase CM, Colvin RB. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997; 64: 1531.
26. Shi C, Lee WS, He Q, et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci USA 1996; 93: 4051.
27. Wehner J, Morrell CN, Reynolds T, et al. Antibody and complement in transplant vasculopathy. Circ Res 2007; 100:191.
28. Nejat S, Zaki A, Hirsch GM, et al. CD8() T cells mediate aortic allo-graft vasculopathy under conditions of calcineurin immunosuppression: Role of IFN-gamma and CTL mediators. Transpl Immunol 2008; 19: 103.
29. Fischbein MP, Yun J, Laks H, et al. CD8 lymphocytes participate in the development of chronic rejection. J Heart Lung Transplant 2001; 20: 228.
30. Fischbein MP, Yun J, Laks H, et al. CD8 lymphocytes augment chronic rejection in a MHC class II mismatched model. Transplantation 2001; 71: 1146.
31. Raisky O, Spriewald BM, Morrison KJ, et al. CD8() T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination. J Heart Lung Transplant 2003; 22: 177.
32. Cerny A, Heusser C, Sutter S, et al. Generation of agammaglobulinae-mic mice by prenatal and postnatal exposure to polyclonal or mono-clonal anti-IgM antibodies. Scand J Immunol 1986; 24: 437.
33. Koulack J, McAlister VC, Giacomantonio CA, et al. Development of a mouse aortic transplant model of chronic rejection. Microsurgery 1995; 16: 110.
34. Wu GD, Jin YS, Salazar R, et al. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: A possible injury pathway contributing to chronic allograft rejection. J Heart Lung Transplant 2002; 21: 1174.
35. Plissonnier D, Henaff M, Poncet P, et al. Involvement of antibody-dependent apoptosis in graft rejection. Transplantation 2000; 69: 2601.
36. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319.
37. Terasaki P, Mizutani K. Antibody mediated rejection: Update 2006. Clin J Am Soc Nephrol 2006; 1: 400.
38. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: A prospective trial. Am J Transplant 2004; 4: 438.
39. Rodriguez ER, Skojec DV, Tan CD, et al. Antibody-mediated rejection in human cardiac allografts: Evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005; 5: 2778.
40. Stastny P, Lavingia B, Fixler DE, et al. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation 2007; 84: 738.
41. Soleimani B, Lechler RI, Hornick PI, et al. Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation. Am J Transplant 2006; 6: 1781.
42. Leech SH, Mather PJ, Eisen HJ, et al. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function. Clin Transplant 1996; 10(6 Pt 2):639.
43. Hosenpud JD, Everett JP, Morris TE, et al. Cardiac allograft vasculopa-thy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995; 92: 205.